Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0.317. It has been cited 5 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0482
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
National Institutes of Health
Grant: 1S10RR026824-01
UPLC with Tandem MS for Sensitive Quantitative Analysis of Small Molecules
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 3UL1TR001079-02S1
Institute for Clinical and Translational Research
National Institutes of Health
Grant: 3UM1CA121947-19S9
Consortium for Advancing Management and Prevention of Cancer in People with HIV
FWCI
0.37
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals